Center for Gerontology and Healthcare Research, School of Public Health, Brown University, Providence, RI; Department of Health Services, Policy, and Practice, School of Public Health, Brown University, Providence, RI.
Center for Gerontology and Healthcare Research, School of Public Health, Brown University, Providence, RI.
J Am Med Dir Assoc. 2019 Dec;20(12):1548-1552. doi: 10.1016/j.jamda.2019.08.030. Epub 2019 Oct 31.
Interventions aimed at managing agitated and aggressive behaviors in dementia without the use of antipsychotics are currently being tested in nursing homes (NHs). Researchers and clinicians require a measure that can capture the severity of residents' behaviors. We test the internal consistency and construct validity of the Agitated and Reactive Behavior Scale (ARBS), a measure created using data from mandatory NH assessments.
Cross-sectional.
The 2016 national sample of 15,326 Centers for Medicare and Medicaid Services-certified NHs. The analytic sample included 489,854 new admissions and 765,367 long-stay residents (at least 90 days in NH). All participants have a dementia diagnosis.
Minimum Data Set (MDS), version 3.0. The ARBS is a composite measure of (1) physical behavioral symptoms directed at other people; (2) verbal behavioral symptoms directed at other people; (3) other behavioral symptoms not directed at other people; and (4) rejection of care. Variables used to establish construct validity included degree of cognitive impairment, use of medications for managing agitation and aggression, and co-occurring conditions associated with agitated and aggressive behaviors (eg, schizophrenia, depression, or delirium).
This report has 3 important findings: (1) the ARBS score has borderline-adequate internal consistency (α = .64-.71) in the national population NH residents with dementia; (2) only 18% of new admissions and 21% of long-stay residents with dementia evidence any agitated or aggressive behaviors in the last week, as rated in the MDS assessment; and (3) the ARBS demonstrates good construct validity; it increases with cognitive impairment, treatment with relevant medications, and co-occurring psychiatric conditions and symptoms.
Nationally available MDS data may significantly underestimate the prevalence of agitated and aggressive behaviors among NH residents with dementia.
Researchers conducting pragmatic trials of non-pharmaceutical interventions to manage behaviors in NH residents with dementia should consider the likely underdetection of these behaviors in the available MDS data.
目前正在养老院(NH)中测试不使用抗精神病药物来管理痴呆症患者激越和攻击行为的干预措施。研究人员和临床医生需要一种能够捕捉居民行为严重程度的措施。我们测试了使用 NH 强制性评估数据创建的激越和反应性行为量表(ARBS)的内部一致性和结构有效性。
横断面。
2016 年全国范围内,经医疗保险和医疗补助服务中心认证的 15326 家 NH 机构的样本。分析样本包括 489854 名新入院患者和 765367 名长期住院患者(在 NH 至少 90 天)。所有参与者均有痴呆症诊断。
最低数据集(MDS),第 3.0 版。ARBS 是对(1)针对他人的身体行为症状;(2)针对他人的言语行为症状;(3)非针对他人的其他行为症状;和(4)拒绝护理的综合衡量标准。用于建立结构有效性的变量包括认知障碍程度、用于管理激越和攻击的药物使用以及与激越和攻击行为相关的共病情况(例如,精神分裂症、抑郁症或谵妄)。
本报告有 3 个重要发现:(1)在全国 NH 痴呆居民人群中,ARBS 评分具有边缘适度的内部一致性(α=.64-.71);(2)在 MDS 评估中,只有 18%的新入院患者和 21%的长期住院痴呆患者在过去一周内出现任何激越或攻击行为;(3)ARBS 具有良好的结构有效性;它随着认知障碍、相关药物治疗以及共病的精神状况和症状而增加。
全国范围内可用的 MDS 数据可能严重低估了 NH 痴呆居民激越和攻击行为的患病率。
对于在 NH 痴呆居民中进行非药物干预行为管理的实用性试验的研究人员,应考虑在现有 MDS 数据中可能对这些行为的检测不足。